ArticleCancers2024

Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma.

Mara Egerer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.